Ischemic hepatitis: Difference between revisions

Jump to navigation Jump to search
Anthony Gallo (talk | contribs)
mNo edit summary
Anthony Gallo (talk | contribs)
mNo edit summary
Line 3: Line 3:
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}


{{SK}} hypoxic hepatitis, shock liver
{{SK}}


==Overview==
==Overview==

Revision as of 19:14, 18 July 2016

WikiDoc Resources for Ischemic hepatitis

Articles

Most recent articles on Ischemic hepatitis

Most cited articles on Ischemic hepatitis

Review articles on Ischemic hepatitis

Articles on Ischemic hepatitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ischemic hepatitis

Images of Ischemic hepatitis

Photos of Ischemic hepatitis

Podcasts & MP3s on Ischemic hepatitis

Videos on Ischemic hepatitis

Evidence Based Medicine

Cochrane Collaboration on Ischemic hepatitis

Bandolier on Ischemic hepatitis

TRIP on Ischemic hepatitis

Clinical Trials

Ongoing Trials on Ischemic hepatitis at Clinical Trials.gov

Trial results on Ischemic hepatitis

Clinical Trials on Ischemic hepatitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ischemic hepatitis

NICE Guidance on Ischemic hepatitis

NHS PRODIGY Guidance

FDA on Ischemic hepatitis

CDC on Ischemic hepatitis

Books

Books on Ischemic hepatitis

News

Ischemic hepatitis in the news

Be alerted to news on Ischemic hepatitis

News trends on Ischemic hepatitis

Commentary

Blogs on Ischemic hepatitis

Definitions

Definitions of Ischemic hepatitis

Patient Resources / Community

Patient resources on Ischemic hepatitis

Discussion groups on Ischemic hepatitis

Patient Handouts on Ischemic hepatitis

Directions to Hospitals Treating Ischemic hepatitis

Risk calculators and risk factors for Ischemic hepatitis

Healthcare Provider Resources

Symptoms of Ischemic hepatitis

Causes & Risk Factors for Ischemic hepatitis

Diagnostic studies for Ischemic hepatitis

Treatment of Ischemic hepatitis

Continuing Medical Education (CME)

CME Programs on Ischemic hepatitis

International

Ischemic hepatitis en Espanol

Ischemic hepatitis en Francais

Business

Ischemic hepatitis in the Marketplace

Patents on Ischemic hepatitis

Experimental / Informatics

List of terms related to Ischemic hepatitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and keywords:

Overview

Ischemic hepatitis (also known as shock liver) is a condition of decreased blood supply to the liver resulting in injury to liver cells (hepatocytes), which occurs in a diffuse fashion.

The decreased blood flow (perfusion) to the liver is usually due to shock or low blood pressure. However, local causes involving the hepatic artery that supplies oxygen to the liver, such as sickle cell crisis and thrombosis of the hepatic artery, can also cause ischemic hepatitis. Patients with ischemic hepatitis are usually very ill.

Blood testing usually shows high levels of the liver transaminase enzymes, AST and ALT, which may exceed 1000 U/L. People who develop ischemic hepatitis may have pain in the right upper part of the abdomen, but they usually feel more unwell because of the serious reason that they developed the ischemia, than due to the ischemic hepatitis itself. Jaundice can occur, but is rare and transient, as is actual loss of function of the liver.

Ischemic hepatitis is related to another condition called congestive hepatopathy or nutmeg liver, which is a backflow condition due to poor drainage of the liver, usually due to heart failure. As a result, the two entities can co-exist.

Template:WH Template:WS